Key Financial’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50.2K Hold
151
– – 0.01% 528
2026
Q2
$56.1K Hold
151
– – 0.01% 512
2026
Q1
$39K Hold
151
– – 0.01% 584
2025
Q4
$37.2K Hold
151
– – 0.01% 590
2025
Q3
$27.1K Hold
151
– – 0.01% 649
2025
Q2
$20.8K Hold
151
– – ﹤0.01% 685
2025
Q1
$27.2K Hold
151
– – 0.01% 591
2024
Q4
$23.7K Hold
151
– – 0.01% 618
2024
Q3
$27.5K Hold
151
– – 0.01% 583
2024
Q2
$27.7K Buy
+151
New +$25.4K 0.01% 578

Other funds holding KRYS

Key Financial's KRYS Position: Q3 2026 in Review

Key Financial held its Krystal Biotech (KRYS) position steady in Q3 2026 at 151 shares worth $50.2K. The position accounts for 0.01% of the portfolio, ranked #528.

Key Financial first reported a position in KRYS in Q2 2024 and has held it in 10 quarters since. The position peaked at $56.1K in Q2 2026. 353 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Key Financial held 151 shares of Krystal Biotech worth $50.2K as of Q3 2026.
  • Key Financial left its Krystal Biotech share count unchanged in Q3 2026.
  • Krystal Biotech made up 0.01% of Key Financial's portfolio in Q3 2026, its #528 holding.
  • Key Financial first reported a position in Krystal Biotech in Q2 2024 and has held it in 10 quarters since.
  • Key Financial's Krystal Biotech position peaked at $56.1K in Q2 2026.
  • 353 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.